Gain Therapeutics (GANX) has shared an update.
Gain Therapeutics, Inc. has entered into an agreement for a public offering, issuing over 7 million shares and pre-funded warrants, aiming to raise around $10.1 million after fees. The warrants can be exercised at a nominal price but are subject to ownership limitations to prevent exceeding set thresholds of company ownership. The deal includes an option for additional share purchases to cover over-allotments, with customary terms and a lock-up period restricting further stock sales. This strategic financial move is designed to bolster the company’s capital, subject to customary closing conditions.
Learn more about GANX stock on TipRanks’ Stock Analysis page.
